Uncoupling	NN
of	IN
the	DT
profibrotic	JJ
and	CC
hemostatic	JJ
effects	NNS
of	IN
thrombin	NN
in	IN
lung	NN
fibrosis	NN
.	.

Fibrotic	JJ
lung	NN
disease	NN
,	,
most	RBS
notably	RB
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
,	,
is	VBZ
thought	VBN
to	TO
result	VB
from	IN
aberrant	JJ
wound-healing	JJ
responses	NNS
to	TO
repetitive	JJ
lung	NN
injury	NN
.	.

Increased	VBN
vascular	JJ
permeability	NN
is	VBZ
a	DT
cardinal	JJ
response	NN
to	TO
tissue	NN
injury	NN
,	,
but	CC
whether	IN
it	PRP
is	VBZ
mechanistically	RB
linked	VBN
to	TO
lung	NN
fibrosis	NN
is	VBZ
unknown	JJ
.	.

We	PRP
previously	RB
described	VBD
a	DT
model	NN
in	IN
which	WDT
exaggeration	NN
of	IN
vascular	JJ
leak	NN
after	IN
lung	NN
injury	NN
shifts	VBZ
the	DT
outcome	NN
of	IN
wound-healing	JJ
responses	NNS
from	IN
normal	JJ
repair	NN
to	TO
pathological	JJ
fibrosis	NN
.	.

Here	RB
we	PRP
report	VBP
that	IN
the	DT
fibrosis	NN
produced	VBN
in	IN
this	DT
model	NN
is	VBZ
highly	RB
dependent	JJ
on	IN
thrombin	NN
activity	NN
and	CC
its	PRP$
downstream	JJ
signaling	NN
pathways	NNS
.	.

Direct	JJ
thrombin	NN
inhibition	NN
with	IN
dabigatran	NN
significantly	RB
inhibited	VBD
protease-activated	JJ
receptor-1	NN
(	(
PAR1	NN
)	)
activation	NN
,	,
integrin	NN
avb6	NN
induction	NN
,	,
TGF-b	NN
activation	NN
,	,
and	CC
the	DT
development	NN
of	IN
pulmonary	JJ
fibrosis	NN
in	IN
this	DT
vascular	JJ
leak-dependent	JJ
model	NN
.	.

We	PRP
used	VBD
a	DT
potentially	RB
novel	JJ
imaging	NN
method	NN
-	:
ultashort	NN
echo	VBP
time	NN
(	(
UTE	NN
)	)
lung	NN
magnetic	JJ
resonance	NN
imaging	NN
(	(
MRI	NNP
)	)
with	IN
the	DT
gadolinium-based	JJ
,	,
fibrin-specific	JJ
probe	NN
EP-2104R	NN
-	:
to	TO
directly	RB
visualize	VB
fibrin	JJ
accumulation	NN
in	IN
injured	JJ
mouse	NN
lungs	NNS
,	,
and	CC
to	TO
correlate	VB
the	DT
antifibrotic	JJ
effects	NNS
of	IN
dabigatran	NN
with	IN
attenuation	NN
of	IN
fibrin	JJ
deposition	NN
.	.

We	PRP
found	VBD
that	IN
inhibition	NN
of	IN
the	DT
profibrotic	JJ
effects	NNS
of	IN
thrombin	NN
can	MD
be	VB
uncoupled	VBN
from	IN
inhibition	NN
of	IN
hemostasis	NN
,	,
as	IN
therapeutic	JJ
anticoagulation	NN
with	IN
warfarin	NN
failed	VBD
to	TO
downregulate	VB
the	DT
PAR1/avb6/TGF-b	NN
axis	NN
or	CC
significantly	RB
protect	VB
against	IN
fibrosis	NN
.	.

These	DT
findings	NNS
have	VBP
direct	JJ
and	CC
important	JJ
clinical	JJ
implications	NNS
,	,
given	VBN
recent	JJ
findings	NNS
that	WDT
warfarin	NN
treatment	NN
is	VBZ
not	RB
beneficial	JJ
in	IN
IPF	NNP
,	,
and	CC
the	DT
clinical	JJ
availability	NN
of	IN
direct	JJ
thrombin	NN
inhibitors	NNS
that	WDT
our	PRP$
data	NNS
suggest	VBP
could	MD
benefit	VB
these	DT
patients	NNS
.	.

